Tuberculosis and Respiratory Diseases

Search: Tuberc Respir Dis Search

CLOSE

Review Article

Tuberculosis

October 30, 2020

An Overview of Genetic Information of Latent Mycobacterium tuberculosis

Faezeh Hamidieh, Parissa Farnia, Jamileh Nowroozi, et al.

Tuberc Respir Dis. 2021;84(1):1-12.

Mycobacterium tuberculosis has infected more than two billion individuals worldwide, of whom 5%–10% have clinically active disease and 90%–95% remain in the latent stage with a reservoir of viable bacteria...

Review Article

Pulmonary Infection

September 4, 2020

COVID-19 Death and BCG Vaccination Programs Worldwide

Feras J. Jirjees, Yahya H. Dallal Bashi, Hala J. Al-Obaidi

Tuberc Respir Dis. 2021;84(1):13-21.

Several clinical trials are being conducted worldwide to investigate the protective effect of the bacillus Calmette-Guérin (BCG) vaccine against death in healthcare providers who are working directly with coronavirus disease...

Review Article

Pulmonary Infection

October 26, 2020

Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?

Belaid Bouazza, Dihia Hadj-Said, Karen A. Pescatore, et al.

Tuberc Respir Dis. 2021;84(1):22-34.

The coronavirus pandemic, known as coronavirus disease 2019 (COVID-19), is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus first identified in patients...

Review Article

COPD

October 13, 2020

Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases

Kartik Deshmukh, Arjun Khanna

Tuberc Respir Dis. 2021;84(1):35-45.

Globally, cardiovascular diseases and chronic obstructive pulmonary disease (COPD) are the leading causes of the noncommunicable disease burden. Overlapping symptoms such as breathing difficulty and fatigue, with a lack of...

Original Article

COPD

September 28, 2020

Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease

Ha Youn Lee, Jin Hwa Song, Ha-Kyeong Won, et al.

Tuberc Respir Dis. 2021;84(1):46-54.

Background: The aim of this study was to investigate inhaler device handling in elderly patients. Inhaler devices with respect to misuse and error correction were also compared. Methods: Inhaler use technique...

Original Article

Miscellaneous

November 30, 2020

Effects of Particulate Matter 10 Inhalation on Lung Tissue RNA expression in a Murine Model

Heejae Han, Eun-Yi Oh, Jae-Hyun Lee, et al.

Tuberc Respir Dis. 2021;84(1):55-66.

Background: Particulate matter 10 (PM10; airborne particles

Original Article

Pleural Diseases

November 9, 2020

Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion

Hossam Hosny Masoud, Mahmoud Mohamed El-Zorkany, Azza Anwar Ahmed, et al.

Tuberc Respir Dis. 2021;84(1):67-73.

Background: Pleurodesis fails in 10%–40% of patients with recurrent malignant pleural effusions malignant pleural effusion and dyspnea. This study aimed to assess the values of pleural elastance (PEL) after the...

Original Article

Tuberculosis

October 28, 2020

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Comparison of Pre- and Post-Public–Private Mix Periods

Yewon Kang, Eun-Jung Jo, Jung Seop Eom, et al.

Tuberc Respir Dis. 2021;84(1):74-83.

Background: This study compared the treatment outcomes of patients with multidrug-resistant tuberculosis (MDR-TB) before and after the implementation of public–private mix (PPM). Factors affecting treatment success were also investigated. Methods: Data...

Current Issue: Volume 84(1); Jan 2021

ARTICLE & TOPICS

Article category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org

Copyright © 2021 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

prev

next

prev

next